Table III.

Multivariate analyses for progression-free survival and overall survival.

	Progression-free survival			Overall survival
Characteristic	HR	95% CI	P-value	HR	95% CI	P-value
Age (continuous variable)	0.97	0.92–1.02	0.30	0.94	0.90–0.99	0.01
Concurrence of endometriosis (yes vs. no)	0.78	0.32–1.86	0.57	0.96	0.47–1.94	0.90
FIGO stage (III/IV vs. I/II)	9.10	3.33–25.0	<0.01	6.17	2.60–14.6	<0.01
Residual tumor (>1 cm vs. ≤1 cm)	1.79	0.68–4.72	0.23	2.72	1.19–6.23	0.02
BAF250a expression (retained vs. deficient)	0.72	0.32–1.74	0.47	0.80	0.39–1.67	0.56

HR, hazard ratio; CI, confidence interval; FIGO, international federation of gynecology and obstetrics.